New cancer clinical trial: A Phase 2 Study Evaluating the Efficacy and Safety of DKN-01 as a Monotherapy or in Combination With Paclitaxel in Patients With Relapsed/ Refractory Endometrioid Endometrial or Endometrioid Ovarian Cancer

Published on: January 10, 2018 at 12:00PM
Conditions:   Endometrial Cancer;   Uterine Cancer;   Ovarian Cancer
Interventions:   Drug: Paclitaxel;   Drug: DKN-01
Sponsor:   Leap Therapeutics, Inc.
Recruiting
http://ift.tt/2moWaCG